AAAAAA

   
Results: 1-10 |
Results: 10

Authors: VERVOORDELDONK SF DOUMAID K REMMERSWAAL EBM TENBERGE IJM WILMINK JM DEWAAL LP BOOG CJP
Citation: Sf. Vervoordeldonk et al., LONG-TERM DETECTION OF MICROCHIMAERISM IN PERIPHERAL-BLOOD AFTER PRETRANSPLANTATION BLOOD-TRANSFUSION, British Journal of Haematology, 102(4), 1998, pp. 1004-1009

Authors: VERVOORDELDONK SF VANDENBERG H VONDEMBORNE AEGK VANLEEUWEN EF SLAPERCORTENBACH ICM
Citation: Sf. Vervoordeldonk et al., OPTIMIZATION OF PURGING OF AUTOLOGOUS BONE-MARROW GRAFTS FOR CHILDRENWITH PRECURSOR-B ACUTE LYMPHOBLASTIC-LEUKEMIA, Journal of hematotherapy, 6(5), 1997, pp. 495-500

Authors: VERVOORDELDONK SF MERLE PA BEHRENDT H STEENBERGEN EJ VANDENBERG H VANWERING ER VONDEMBORNE AEGK VANDERSCHOOT CE VANLEEUWEN EF SLAPERCORTENBACH ICM
Citation: Sf. Vervoordeldonk et al., PCR-POSITIVITY IN HARVESTED BONE-MARROW PREDICTS RELAPSE AFTER TRANSPLANTATION WITH AUTOLOGOUS PURGED BONE-MARROW IN CHILDREN IN 2ND REMISSION OF PRECURSOR B-CELL ACUTE-LEUKEMIA, British Journal of Haematology, 96(2), 1997, pp. 395-402

Authors: VERVOORDELDONK SF HEIKENS J GOEDEMANS WT MERLE PA VONDEMBORNE AEGK VANROYEN EA SLAPERCORTENBACH ICM VANOERS RHJ
Citation: Sf. Vervoordeldonk et al., TC-99M-CD19 MONOCLONAL-ANTIBODY IS NOT USEFUL FOR IMAGING OF B-CELL NON-HODGKINS-LYMPHOMA, Cancer immunology and immunotherapy, 42(5), 1996, pp. 291-296

Authors: VERVOORDELDONK SF BALKENENDE AY VANDENBERG H VONDEMBORNE AEGK VANDERSCHOOT CE VANLEEUWEN EF SLAPERCORTENBACH ICM
Citation: Sf. Vervoordeldonk et al., DEGRADATION OF RADIOIODINATED B-CELL MONOCLONAL-ANTIBODIES - INHIBITION VIA A FC-GAMMA-RECEPTOR-II-MEDIATED MECHANISM AND BY DRUGS, Cancer immunology and immunotherapy, 42(1), 1996, pp. 24-30

Authors: VERVOORDELDONK SF MERLE PA BEHRENDT H STEENBERGEN EJ VANLEEUWEN EF VANDENBERG H VONDEMBORNE AEGK VANDERSCHOOT CE SLAPERCORTENBACH ICM
Citation: Sf. Vervoordeldonk et al., TRIPLE IMMUNOFLUORESCENCE STAINING FOR PREDICTION OF RELAPSE IN CHILDHOOD PRECURSOR-B ACUTE LYMPHOBLASTIC-LEUKEMIA, British Journal of Haematology, 92(4), 1996, pp. 922-928

Authors: VERVOORDELDONK SF MERLE PA VANLEEUWEN EF VONDEMBORNE AEGK SLAPERCORTENBACH ICM
Citation: Sf. Vervoordeldonk et al., PRECLINICAL STUDIES WITH RADIOLABELED MONOCLONAL-ANTIBODIES FOR TREATMENT OF PATIENTS WITH B-CELL MALIGNANCIES, Cancer, 73(3), 1994, pp. 1006-1011

Authors: VERVOORDELDONK SF MERLE PA VANLEEUWEN EF VANDERSCHOOT CE VONDEMBORNE AEGK SLAPERCORTENBACH ICM
Citation: Sf. Vervoordeldonk et al., FC-GAMMA RECEPTOR-II (CD32) ON MALIGNANT B-CELLS INFLUENCES MODULATION INDUCED BY ANTI-CD19 MONOCLONAL-ANTIBODY, Blood, 83(6), 1994, pp. 1632-1639

Authors: VERVOORDELDONK SF MERLE PA VANLEEUWEN EF VANDERSCHOOT CE VONDEMBORNE AEGK SLAPERCORTENBACH ICM
Citation: Sf. Vervoordeldonk et al., THE INFLUENCE OF FC-GAMMA-RECEPTOR EXPRESSION ON MALIGNANT B-CELLS ONANTIGEN MODULATION IN MONOCLONAL-ANTIBODY THERAPY, Experimental hematology, 21(8), 1993, pp. 1116-1116

Authors: VERVOORDELDONK SF MERLE PA VANLEEUWEN EF VANDERSCHOOT CE VONDEMBORNE AEGK SLAPERCORTENBACH ICM
Citation: Sf. Vervoordeldonk et al., TRIPLE IMMUNOFLUORESCENCE STAINING FOR DETECTION OF MINIMAL RESIDUAL DISEASE IN CHILDREN WITH COMMON ACUTE LYMPHOBLASTIC-LEUKEMIA, Blood, 82(10), 1993, pp. 10000551-10000551
Risultati: 1-10 |